BioSpecifics Technologies (BSTC) Halves Q4 Net Income to 1c/Share
Tweet
Share
E-mailGet Alerts BSTC Hot Sheet
Price: $88.53 --0%
Financial Fact:
Operating income (loss): 4.73M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Operating income (loss): 4.73M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
BioSpecifics Technologies (NASDAQ: BSTC) reported Q4 EPS of $0.01, versus $0.02 reported last year. Revenue for the quarter came in at $2.6 million, versus $1.1 million reported last year.
For earnings history and earnings-related data on BioSpecifics Technologies (BSTC) click here.
For earnings history and earnings-related data on BioSpecifics Technologies (BSTC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies sees a buying opportunity in this S&P 500 sector
- Jefferies upgrades Five Below to Buy, sees path to TJX-like re-rating
- Wolfe Research upgrades Biogen, AbbVie on pipeline strength and valuation
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
